Latest news with #End-OCheck


Time of India
2 days ago
- Health
- Time of India
Apollo Cancer Centres launches early detection program for women's cancers
New Delhi: Apollo Cancer Centres (ACCs) has launched End-O Check , an early detection program for women aged 45 and above. The initiative is indicated to focus on identifying endometrial and ovarian cancers—two of the most common gynaecologic cancers —at an early, more treatable stage. The program aims to raise awareness of symptoms, support timely diagnosis in high-risk groups, and promote preventive care, encouraging women to take proactive measures for their gynaecologic health. Dr Pakhee Agarwal, Senior Consultant – Gynaecology Oncology & Robotic Surgery, Apollo Cancer Centre, New Delhi, said, ' Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. Global data indicates a five years survival rate of around 96 per cent for localized disease. However, survival rates drop substantially when diagnosis is delayed, underscoring the importance of timely detection. Key risk factors include obesity, diabetes, early menstruation, late menopause, and polycystic ovary syndrome (PCOS), all of which are becoming more prevalent among Indian women.' Dr. Reeti, Senior Consultant, Radiology Department, Apollo Cancer Centre, New Delhi, said, 'Radiology plays a crucial role in the early detection of gynaecologic cancers . Through End-O Check, we are integrating transvaginal ultrasonography (TVS) as the diagnostic tool to help identify subtle changes that could indicate early-stage ovarian or endometrial cancers. Early imaging intervention allows clinicians to act promptly, improving treatment options and outcomes for patients."


Time of India
6 days ago
- Health
- Time of India
Apollo Hospitals launches ‘End-O Check' to boost early detection of cancers
CHENNAI: Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) have launched 'End-O Check', a specialised screening and diagnostic initiative for the early detection of ovarian and endometrial cancers in women, particularly those in the postmenopausal age group. Tired of too many ads? go ad free now The programme, unveiled on July 30, offers risk-based assessments, diagnostic tests, and symptom evaluation to enable early identification of two of the most prevalent gynaecological cancers. Doctors say timely diagnosis can drastically improve survival outcomes, especially in the case of ovarian cancer, often dubbed the 'silent killer,' which is typically diagnosed at an advanced stage. Speaking at the launch, Dinesh Madhavan, president, group oncology & international, Apollo Hospitals, said, 'Early detection remains our most powerful ally in improving survival and quality of life. End-O Check is a proactive step towards shifting the narrative to early diagnosis and precision treatment.' A panel discussion held alongside the launch featured senior oncologists including Dr Ajit Pai, Dr Venkat P, Dr Kumar Gubbala, Dr Madhu Priya and Dr Priya Kapoor. The session emphasised the need for greater awareness, timely intervention, and busting myths that deter women from seeking early care. According to the doctors, India's cancer burden is projected to rise to 1.57 million cases by 2025, with ovarian and uterine cancers among the top five affecting women. The age-standardized incidence rate for ovarian cancer is 4.6 per 100,000 and 2.5 for uterine cancers. 'Reproductive pattern changes, urban lifestyles, and increasing metabolic conditions are all contributing to the rise,' said Dr Kumar Gubbala, consultant – gynaecologic oncology, APCC. Endometrial cancer, though more likely to present symptoms like unexpected bleeding or abnormal discharge, often goes unreported until it's too late, doctors said. Tired of too many ads? go ad free now 'End-O Check is more than just screening—it's about awareness and access,' said Karan Puri, CEO, Apollo Cancer Centres & APCC. 'When cancers are caught early, the treatments are often simpler, less invasive, and significantly more effective,' he said. Apollo officials said the programme would be rolled out across its cancer centres and it would include both clinical consultations and public education efforts, aiming at empowering more women to take proactive steps toward their gynaecologic health.


Time of India
01-08-2025
- Health
- Time of India
Apollo Cancer Centres Launches Early Detection program for Gynaecological Cancers
Bangalore: Apollo Cancer Centres (ACCs) has launched End-O Check , an early detection programme aimed at women aged 45 and above, focusing on endometrial and ovarian cancers. The two gynaecological cancers are among the most common and often go undetected until advanced stages. According to the hospital, End-O Check is intended to support early identification in higher-risk populations, increase symptom awareness, and enable timely clinical intervention. The initiative is intended to encourage women to be proactive in monitoring their gynaecologic health. Dr. Aruna R Patil, Senior Consultant and Head of Department of Radiology, Apollo Cancer Centre, Bangalore, said, 'Radiology plays a crucial role in the early detection of gynaecologic cancers. Through End-O Check, we are integrating transvaginal ultrasonography (TVS) as the diagnostic tool to help identify subtle changes that could indicate early-stage ovarian or endometrial cancers. Early imaging intervention allows clinicians to act promptly, improving treatment options and outcomes for patients."


The Hindu
30-07-2025
- Health
- The Hindu
Apollo launches ‘End-O Check' for early detection of ovarian cancer
Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) launched End-O Check, an early detection programme for ovarian and endometrial cancers. Targetting postmenopausal women and those in high-risk groups, the initiative combines risk-based assessments, symptom evaluation, and diagnostic testing. At the launch, a panel discussion brought together experts from Apollo centres to stress the need for awareness, early diagnosis, and access to preventive tools. The panel featured Ajit Pai, senior consultant, surgical oncology, ACC-Teynampet, P. Venkat, senior consultant, surgical oncology, ACC-Teynampet, Kumar Gubbala, consultant, gynaecological oncology, APCC, Madhu Priya, senior consultant, surgical oncology, ACC-Vanagaram, and Priya Kapoor, consultant, surgical oncology, ACC-Teynampet. The discussion was moderated by Ayyappan, senior consultant, surgical oncology, ACC-Teynampet. Ovarian cancer, often termed a silent killer, typically affects women between 55 and 64 years. Early-stage detection can push survival rates beyond 90%, but vague symptoms often delay diagnosis. Endometrial cancer, on the other hand, frequently presents with signs such as abnormal bleeding, yet many women fail to seek timely care. Dr. Madhu Priya also highlighted the importance of ovum preservation for younger women undergoing cancer treatment. 'Freezing eggs for fertility preservation gives women the option to protect their ability to have biological children after cancer treatment. Including this as part of cancer care supports informed, compassionate, and holistic treatment planning,' she said. Dinesh Madhavan, President, Group Oncology and International, Apollo Hospitals, called the initiative a shift from treatment to early detection. With India's cancer burden projected to rise, End-O Check seeks to help women to take charge of their gynaecologic health through education, screening as well as early intervention.


Time of India
30-07-2025
- Health
- Time of India
Early detection prog for endometrial, ovarian cancer in women launched
Mysuru: Surgery is the primary treatment for two of the most prevalent gynaecological cancers, Apollo BGS Hospitals surgical oncologist Dr Y Ramya said on Wednesday. She highlighted that advances in minimally invasive surgery and cytoreductive surgery have helped patients to have a faster and better recovery. Speaking to reporters during the launch of Apollo Cancer Centre's End-O Check, a comprehensive early detection programme targeting women aged 45 and above, she stated that the initiative is designed to detect endometrial and ovarian cancer at an early and more treatable stage. Ovarian cancer is a silent killer as the majority of women come to the hospital only in the advanced stage due to non-specific early symptoms. "Endometrial cancers can be picked up very early due to early presentation. Still, patients approach us in late stages due to negligence or lack of awareness. Both cancers are curable if detected and treated in the early stages," Ramya said. Dr Vanitha LV, senior consultant–obstetrics & gynaecology at Apollo BGS Hospitals, said, "Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like LeafFilter turns your gutter to-dos … to done. LeafFilter Gutter Protection Learn More Undo Global data indicates a five-year survival rate of around 96% for localised disease. Key risk factors include obesity, diabetes, early menstruation, and late menopause, all of which are becoming more prevalent among Indian women. " Dr Naveen Jayaram, consultant medical oncologist, said, "Ovarian cancer is the third most common cancer in India, with a younger median age of diagnosis (50–56 years) compared to the West (around 63 years). Over 70% of Indian women are diagnosed at an advanced stage due to vague early symptoms and lack of effective screening. Common symptoms include abdominal pain, bloating, and gastrointestinal issues. Advanced-stage survival averages 20-30 months, while early-stage survival can exceed 80%. " Dr Ranjitha V N, consultant oncopathologist, was present.